(5Z)-7-[(1α,4α)-3β-[(1E,3S)-3-Hydroxy-1-octenyl]-7-oxabicyclo[2.2.1]heptane-2α-yl]-5-heptenoic acid

Names

[ Name ]:
(5Z)-7-[(1α,4α)-3β-[(1E,3S)-3-Hydroxy-1-octenyl]-7-oxabicyclo[2.2.1]heptane-2α-yl]-5-heptenoic acid

[Synonym ]:
(Z)-7-[(1S,2R,3R,4R)-3-((E)-(S)-3-Hydroxy-oct-1-enyl)-7-oxa-bicyclo[2.2.1]hept-2-yl]-hept-5-enoic acid
15-epi-9a-homo-(11,12)-deoxathromboxane A2

Biological Activity

[Description]:

SQ 26655 is a TxA2 receptor agonist. SQ 26655 induces human platelet aggregation[1].

[Related Catalog]:

Research Areas >> Cardiovascular Disease

Signaling Pathways >> GPCR/G Protein >> Prostaglandin Receptor

[Target]

TxA2 receptor[1].

[References]

[1]. Harris DN, et al. Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle. Eur J Pharmacol. 1984 Aug 3;103(1-2):9-18.

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₁H₃₄O₄

[ Molecular Weight ]:
350.49200

[ Exact Mass ]:
350.24600

[ PSA ]:
66.76000

[ LogP ]:
4.47860

(5Z)-7-[(1α,4α)-3β-[(1E,3S)-3-Hydroxy-1-octenyl]-7-oxabicyclo[2.2.1]heptane-2α-yl]-5-heptenoic acid

Names

Biological Activity

Chemical & Physical Properties

Related Compounds